mizoribine has been researched along with Adverse Drug Event in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Hama, R | 1 |
| Nishimura, H; Nomura, T; Shiota, K; Uwabe, C | 1 |
1 review(s) available for mizoribine and Adverse Drug Event
| Article | Year |
|---|---|
Clinical cases and problems of delayed (tardive) reactions to drugs--for pharmaceuticals in general.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Anti-Arrhythmia Agents; Clinical Trials as Topic; Disopyramide; Drug-Related Side Effects and Adverse Reactions; Forecasting; Heart; Humans; Japan; Pharmaceutical Preparations; Ribonucleosides; Toxicity Tests | 1996 |
2 other study(ies) available for mizoribine and Adverse Drug Event
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Joint study on the teratogenic sensitivity of the Pika (Ochotona rufescens rufescens) to selected drugs.
Topics: 6-Aminonicotinamide; Abnormalities, Drug-Induced; Animals; Body Weight; Cyclophosphamide; Drug-Related Side Effects and Adverse Reactions; Female; Lagomorpha; Male; Mammals; Mutagenicity Tests; Pregnancy; Pregnancy, Animal; Ribonucleosides; Vitamin A | 1986 |